Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by GGORI94on Jan 24, 2017 2:26pm

71 Views

Post# 25748289

RE:GGORI 94 Fake Account Join Date Sept 2016

Yeah, fake account... Thats why Im ignored by 1 person while you're ignored by 40 something. I have posts/investments in OGI, ACG, EAT, NF and CGC the only reason I post mostly on here is because this company seems to get it the worst from bashers.

Bullboard Posts

How a junior advances one of the largest undeveloped diamond projects